These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 21597537)
1. Opioid substitution therapy--a study of GP participation in prescribing. Scarborough J; Eliott J; Braunack-Mayer A Aust Fam Physician; 2011 Apr; 40(4):241-5. PubMed ID: 21597537 [TBL] [Abstract][Full Text] [Related]
2. Methadone and buprenorphine prescribing patterns of Victorian general practitioners: their first 5 years after authorisation. Longman C; Lintzeris N; Temple-Smith M; Gilchrist G Drug Alcohol Rev; 2011 Jul; 30(4):355-9. PubMed ID: 21355929 [TBL] [Abstract][Full Text] [Related]
3. Reluctant to train, reluctant to prescribe: barriers to general practitioner prescribing of opioid substitution therapy. Longman C; Temple-Smith M; Gilchrist G; Lintzeris N Aust J Prim Health; 2012; 18(4):346-51. PubMed ID: 22950844 [TBL] [Abstract][Full Text] [Related]
4. A literature review of international implementation of opioid substitution treatment in prisons: equivalence of care? Larney S; Dolan K Eur Addict Res; 2009; 15(2):107-12. PubMed ID: 19182485 [TBL] [Abstract][Full Text] [Related]
5. [Questionnaire study of general practitioners regarding experience and attitude to opioid substitution therapy]. Mravcík V; Coufalová M; Popov P; Zábranský T; Procházka R Epidemiol Mikrobiol Imunol; 2005 Feb; 54(1):27-33. PubMed ID: 15810140 [TBL] [Abstract][Full Text] [Related]
7. Prescribers' perceptions of the diversion and injection of medication by opioid substitution treatment patients. Larance B; Degenhardt L; O'Brien S; Lintzeris N; Winstock A; Mattick RP; Bell J; Ali R Drug Alcohol Rev; 2011 Nov; 30(6):613-20. PubMed ID: 21355939 [TBL] [Abstract][Full Text] [Related]
8. Long-term self-treatment with methadone or buprenorphine as a response to barriers to opioid substitution treatment: the case of Sweden. Richert T; Johnson B Harm Reduct J; 2015 Feb; 12():1. PubMed ID: 25889208 [TBL] [Abstract][Full Text] [Related]
9. Dispensing opioid substitution treatment: practices, attitudes and intentions of community-based pharmacists. Lawrinson P; Roche A; Terao H; Le PP Drug Alcohol Rev; 2008 Jan; 27(1):47-53. PubMed ID: 18034381 [TBL] [Abstract][Full Text] [Related]
10. Factors associated with the prescribing of buprenorphine or methadone for treatment of opiate dependence. Ridge G; Gossop M; Lintzeris N; Witton J; Strang J J Subst Abuse Treat; 2009 Jul; 37(1):95-100. PubMed ID: 19004598 [TBL] [Abstract][Full Text] [Related]
11. The impact of methadone or buprenorphine treatment and ongoing injection on highly active antiretroviral therapy (HAART) adherence: evidence from the MANIF2000 cohort study. Roux P; Carrieri MP; Villes V; Dellamonica P; Poizot-Martin I; Ravaux I; Spire B; Addiction; 2008 Nov; 103(11):1828-36. PubMed ID: 18778390 [TBL] [Abstract][Full Text] [Related]
12. The rise of buprenorphine prescribing in England: analysis of NHS regional data, 2001-03. de Wet CJ; Reed LJ; Bearn J Addiction; 2005 Apr; 100(4):495-9. PubMed ID: 15784064 [TBL] [Abstract][Full Text] [Related]
13. Uptake and delivery of hepatitis C treatment in opiate substitution treatment: perceptions of clients and health professionals. Treloar C; Newland J; Rance J; Hopwood M J Viral Hepat; 2010 Dec; 17(12):839-44. PubMed ID: 20070504 [TBL] [Abstract][Full Text] [Related]
14. Fast-tracking implementation through trial design: the case of buprenorphine treatment in Victoria. Bammer G; Ritter A; Kutin JJ; Lintzeris N Aust N Z J Public Health; 2009 Feb; 33(1):34-9. PubMed ID: 19236356 [TBL] [Abstract][Full Text] [Related]
15. How to overcome hurdles in opiate substitution treatment? A qualitative study with general practitioners in Belgium. Fraeyman J; Symons L; Van Royen P; Van Hal G; Peremans L Eur J Gen Pract; 2016 Jun; 22(2):134-40. PubMed ID: 26799738 [TBL] [Abstract][Full Text] [Related]
16. Buprenorphine prescribing practices and exposures reported to a poison center--Utah, 2002-2011. Centers for Disease Control and Prevention (CDC) MMWR Morb Mortal Wkly Rep; 2012 Dec; 61(49):997-1001. PubMed ID: 23235296 [TBL] [Abstract][Full Text] [Related]
17. Factors affecting feasibility and acceptability of a practice-based educational intervention to support evidence-based prescribing: a qualitative study. Watkins C; Timm A; Gooberman-Hill R; Harvey I; Haines A; Donovan J Fam Pract; 2004 Dec; 21(6):661-9. PubMed ID: 15528289 [TBL] [Abstract][Full Text] [Related]
18. Maintenance drugs to treat opioid dependence. Farrell M; Wodak A; Gowing L BMJ; 2012 May; 344():e2823. PubMed ID: 22589497 [No Abstract] [Full Text] [Related]
19. Key findings from the WHO collaborative study on substitution therapy for opioid dependence and HIV/AIDS. Lawrinson P; Ali R; Buavirat A; Chiamwongpaet S; Dvoryak S; Habrat B; Jie S; Mardiati R; Mokri A; Moskalewicz J; Newcombe D; Poznyak V; Subata E; Uchtenhagen A; Utami DS; Vial R; Zhao C Addiction; 2008 Sep; 103(9):1484-92. PubMed ID: 18636999 [TBL] [Abstract][Full Text] [Related]
20. The general practitioner pharmacotherapy prescribing workforce: examining sustainability from a systems perspective. Hotham E; Roche A; Skinner N; Dollman B Drug Alcohol Rev; 2005 Sep; 24(5):393-400. PubMed ID: 16298833 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]